RACHEL MUEHLFELD: Open Payments
NPI 1487255493 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,208 in 78 payments from 19 companies in 2025. Trend: 2023 $1,507 · 2024 $1,559 · 2025 $1,208
Food & beverage: $1,175Education: $32
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $231 |
| Astellas Pharma US Inc | 10 | $168 |
| ABBVIE INC. | 17 | $141 |
| Dexcom, Inc. | 6 | $125 |
| Amgen Inc. | 6 | $107 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| GlaxoSmithKline, LLC. | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| Corcept Therapeutics | 2 | $42 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
Products named: Ozempic, Veozah, Dexcom G6 Transmitter, OTEZLA, REXULTI, UBRELVY, Wegovy, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
